Pharmavet

What Pharmavet does

Pharmavet is an Australian privately held contract manufacturer that produces veterinary medicines and pet care products on behalf of other companies. Founded in 1993 and headquartered at 92 Antimony Street, Carole Park, Queensland, the company operates as a fully accredited APVMA licensed manufacturing facility and holds a Schedule 4 drug manufacturing licence from Queensland Health, allowing it to legally produce veterinary and APVMA-regulated products including prescription animal medicines. All products bear the Australian Made and Australian Owned logo. The target customer base comprises veterinary product companies, pet care brands, and pesticide manufacturers that require licensed, GMP-compliant manufacturing capacity without investing in their own facilities.

The company's core technology is organised around three dose-form manufacturing capabilities. Solid Dose manufacturing uses three Manesty tablet presses (D-press, BB3B, B3B) producing tablets from 200mg to 2.5g, with standard and custom tooling, de-dusting, coating, and bottling or blister packing. Semi-Solid Dose manufacturing covers pastes, gels, creams, ointments and lotions with heating and emulsifying capability, packed into syringes (5g-80g), jars, or tubes (10ml-250ml). Liquid Dose manufacturing handles free-flowing fluids from 20ml to 20L, including IBC bulk filling, induction sealing, cartoning, and heat shrink wrapping. Staff hold or are completing Certificate III in Process Manufacturing, and GMP criteria are strictly adhered to.

Pharmavet operates a B2B direct sales motion, with prospective clients making contact via the company website ([email protected], 07 3271 4411) to obtain custom quotes. Revenue is generated through multi-year contract manufacturing engagements; pricing is not publicly disclosed and is negotiated per project. Distribution is direct to client brands, with Pharmavet bearing no consumer-facing go-to-market or retail presence. The company is single-site (Carole Park, Queensland) and serves the Australian domestic market exclusively. No parent company, subsidiaries, institutional investors, partnerships, or M&A activity are disclosed.

Name

Pharmavet

Legal name

Pharmavet

Website

https://pharmavet.net.au

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Short description

Pharmavet is a privately held Australian contract manufacturer that produces veterinary medicines and pet care products in solid, semi-solid, and liquid dose forms for other companies. Operating since 1993 from Carole Park, Queensland, it holds APVMA and Schedule 4 drug manufacturing licences.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Medicated Feed Additives & Premixes (Veterinary Pharmaceuticals) (HLAMAEAN)

Keywords

• Contract pharmaceutical manufacturing
• Veterinary medicine manufacturing
• APVMA licensed manufacturing
• Pet care product manufacturing
• GMP contract manufacturer

Headquarters

HQ city

Brisbane

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D

Revenue model

1. Contract Manufacturing Services: Pharmavet generates revenue through contract manufacturing of veterinary and APVMA regulated products for clients. They manufacture products across solid dose, semi-solid dose, and liquid dose forms, providing end-to-end manufacturing including filling and packing services. Products bear the Australian Made and Australian Owned logo.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Pharmavet is an APVMA-licensed contract manufacturer that produces veterinary medicines, pet care products, and APVMA-regulated pesticide formulations for client brands. The company manufactures solid dose (tablets, capsules, powders), semi-solid dose (pastes, gels, creams, ointments, lotions), and liquid dose (oral medications, insect repellents, shampoos) products, with in-house filling, labelling, and packing services delivered under GMP at its Carole Park, Queensland facility.

Product overview

Pharmavet is a contract manufacturing company offering APVMA-licensed manufacturing services for veterinary and pesticide products. The company operates as a single unified service offering (not a software platform) and provides three distinct dose-form manufacturing capabilities: Solid Dose (tablets, capsules, powders), Semi-Solid Dose (pastes, gels, creams, ointments), and Liquid Dose (oral medications, insect repellents, shampoos). All products are manufactured in Queensland, Australia, under GMP standards and bear the Australian Made and Australian Owned logo.

Differentiator

Problem solved

Functional benefit

Products and services

• Solid Dose Contract Manufacturing Contract manufacturing of solid dose veterinary and APVMA-regulated products including tablets, capsules and powders. Tabletting uses three Manesty presses (D-press, BB3B, B3B) producing tablets from 200mg to 2.5g with standard or custom tooling, de-dusting, film or sugar coating, and packaging via tablet bottling with counting or blister packing. Offered to veterinary product brands, pet care companies, and APVMA-regulated product owners in Australia.
• Semi-Solid Dose Contract Manufacturing Contract manufacturing of semi-solid dose veterinary and APVMA-regulated products including pastes, gels, ointments, creams and lotions. Includes heating and emulsifying capabilities for various consistencies, fillers with heated jackets and stirrers for products solid at room temperature, and packing into syringes (5g to 80g), jars, or tubes (10ml to 250ml). Offered to veterinary product brands, pet care companies, and APVMA-regulated product owners in Australia.
• Liquid Dose Contract Manufacturing Contract manufacturing of free-flowing liquid dose veterinary and APVMA-regulated products including oral medications, insect repellents, and shampoos. Fill sizes range from 20ml to 20L, with capabilities for bulk IBC filling, tube and pot filling (10ml-250ml), round bottle and front-and-back labelling, induction sealing, cartoning, and heat shrink wrapping. Offered to veterinary product brands, pet care companies, and APVMA-regulated pesticide manufacturers in Australia.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators1 record

Recent moves4 records

Broad incumbents

• Dechra Pharmaceuticals: Specialty animal health pharmaceutical company developing and manufacturing veterinary medicines across multiple dosage forms. Comparable through its veterinary pharmaceutical product range and reliance on third-party manufacturing partners in some markets.
• PCI Pharma Services: Global pharmaceutical CDMO offering drug manufacturing, packaging and clinical trial services. Comparable as a competitor and benchmark for Pharmavet's contract manufacturing business model.
• Huvepharma: Global animal health and nutrition company with internal manufacturing of veterinary pharmaceuticals and feed additives. Comparable through its veterinary pharmaceutical product portfolio that overlaps with Pharmavet's contract manufacturing offerings.
• Vetoquinol: Independent global animal health company with vertically integrated manufacturing of veterinary medicines. Comparable as a competitor and potential customer for contract manufacturing services in veterinary pharmaceuticals.
• Virbac: Global animal health company with significant in-house manufacturing of veterinary medicines across solid, liquid and injectable formats. Comparable as a producer of regulated veterinary pharmaceuticals that could also be a potential customer or acquirer of Pharmavet.
• Catalent: Large global pharmaceutical CDMO with capabilities across solid, semi-solid and liquid dose manufacturing. Comparable through contract manufacturing business model, though focused on human pharmaceuticals rather than veterinary.

Direct peers

• IDT Australia: Australian pharmaceutical contract manufacturer offering sterile and non-sterile manufacturing, packaging and laboratory services. Directly comparable as a domestic Australian CDMO serving regulated product manufacturers, though more diversified into human pharmaceuticals.
• Argenta: New Zealand-based animal health contract development and manufacturing organisation (CDMO) producing veterinary therapeutics and dosage forms. Directly comparable to Pharmavet in business model, regulatory licensing and animal health focus, but operates at significantly larger scale across multiple sites.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/pharmavet

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmavet